Implantica
Share:
Subscribe:
news.cision.com
/
Implantica
/
Implantica completes Human Factors Validation Study for RefluxStop™ as part of the US FDA Premarket Approval Process
/
REFLUXSTOP
2 of 2
REFLUXSTOP
Tue, Mar 26, 2024 08:00 CET
Low resolution
Medium resolution
Original resolution
Subscribe
Related Releases
Implantica announces two new RefluxStop™ University Hospitals in Spain, leading to 10 active centers and many more to join soon
Wed, Dec 18, 2024 08:30 CET
Implantica announces excellent data from an independent study of 158 RefluxStop™ patients from two centers in Germany – presented at the AUGIS meeting in UK
Wed, Sep 18, 2024 08:30 CET
Implantica announces the eighth RefluxStop™ center of excellence in Italy
Tue, May 14, 2024 08:00 CET
